https://serd.ademe.fr/
La Semaine Européenne de la Réduction des Déchets (SERD) - Ademe SERD
Jul 6, 2026 - La Semaine européenne de la réduction des déchets mobilise partout en France pour agir, sensibiliser et réduire les déchets au quotidien.
la semainedeserd
https://archlinux.org/packages/extra/x86_64/serd-docs/
Arch Linux - serd-docs 0.32.8-1 (x86_64)
arch linux8 1serddocs0
https://www.aacr.org/patients-caregivers/progress-against-cancer/new-oral-serd-approved-for-certain-estrogen-receptor-mutated-breast-cancers/
New Oral SERD Approved for Certain Breast Cancers | Research | AACR
Oct 1, 2025 - The FDA approved imlunestrant for certain patients with advanced ESR1-mutated breast cancer that has progressed following previous therapy.
approved forbreast cancersneworalserd
https://www.staples.com/Serd-FX80/cat_CL90000015017
Serd FX80 | Staples
Buy Serd FX80 at Staples and get Free next-day delivery when you spend $35+.
serdstaples
https://serdart.fr/
Serigraphie Artistique Artisanale | Atelier Serd'art
serigraphieartistiqueartisanaleatelierserd
https://elifesciences.org/articles/37161v1/peer-reviews
Peer review in The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone...
https://www.fiercebiotech.com/biotech/roches-oral-serd-goes-2-2-hitting-goal-phase-3-adjuvant-breast-cancer-trial
Roche's oral SERD hits goal in adjuvant breast cancer phase 3
Nov 18, 2025 - The interim analysis positions giredestrant for use in the adjuvant setting, setting Roche up to target an unoccupied niche of a competitive market.
https://elifesciences.org/articles/37161v1/figures
Figures and data in The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone...
https://www.fiercebiotech.com/biotech/astrazeneca-camizestrant-ambitions-stumble-fda-panel-rejects-novel-oral-serd-proposal
FDA panel rejects AstraZeneca's novel oral SERD proposal
Apr 30, 2026 - By a vote of 6-to-3, an FDA expert panel shot down AstraZeneca's novel proposal of using its oral SERD camizestrant as a first-line switch therapy.
fdapanelrejectsastrazenecanovel
https://www.prnewswire.com/news-releases/global-4-billion-serd-therapeutics-market-to-2030-faslodex-rad1901-gdc-9545-azd9833-sar439859-301279118.html
Global $4+ Billion SERD Therapeutics Market to 2030: Faslodex, RAD1901, GDC-9545, AZD9833, SAR439859
/PRNewswire/ -- The "Global SERD Therapeutics Market 2019-2030: Focus on Product, Therapy, Country Data (14 Countries), and Competitive Landscape" report has...